Futu to Report Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026

(NasdaqGM:FUTU), HONG KONG, Feb. 24, 2026 (GLOBE NEWSWIRE) — Futu Holdings Limited (“Futu” or the “Company”) (Nasdaq: FUTU), a leading tech-driven online brokerage and wealth management platform, today announced that it will report its financial results for the fourth quarter and full year ended December 31, 2025, before U.S. markets open on March 12, 2026. […]

Research Finds Triple-Digit ROI in Market Data Management Technology

New York, Feb. 24, 2026 (GLOBE NEWSWIRE) — New York, NY – February 24, 2026, TRG Screen, the leading provider of market data and subscription cost management technology solutions, announced the results of an independent return-on-investment (ROI) study examining the impact of proactive market data management. Building on the findings, the company has launched an

Amber Therapeutics strengthens its Board and Leadership team, opens UK headquarters and expands EU feasibility study for mixed urinary incontinence, increasing momentum towards a pivotal trial in the US

Oxford, UK – 24 February 2026 – Amber Therapeutics today announced a series of updates to its business highlighting the significant progress it has made since closing its $100 million (£80 million) Series A financing in July 2024–one of the largest Series A rounds ever raised by a European medical technology company. New appointees to

Aebi Schmidt Group closes 2025 with exceptional order momentum, record Order Backlog, and significantly improved profitability; provides 2026 Financial Guidance and Board Update

(NasdaqGM:AEBI), Exceptional order momentum with Order Intake in Q4 2025 increasing 46% vs Q4 2024, Order Backlog further grew to a multi-year record high of over $1.2b, providing a solid basis for 2026 growth Strong Net Sales of $528m in Q4 2025, up 6% vs Q4 2024. Net Sales in Full Year2 2025 increased 2%

The World’s Most Important Residence and Citizenship Programs in 2026

LONDON, Feb. 24, 2026 (GLOBE NEWSWIRE) — While European programs continue to set the benchmark globally, the latest rankings in the 2026 edition of Henley & Partners' Residence and Citizenship Programs report reveal a marked recalibration in the investment migration landscape. Europe's appeal is increasingly being challenged by dynamic competitors across the Middle East, Asia-Pacific,

Ogury Extends Persona-Based Advertising to Connected TV

Ogury today announced the availability of its persona-based advertising solution on Connected TV (CTV), enabling advertisers to activate the same personas consistently across screens as part of a multi-channel strategy that supports brand outcomes. As audiences fragment across screens, maintaining consistent targeting in multiple environments has become increasingly difficult for advertisers. With persona-based advertising now

Research Finds Triple-Digit ROI in Market Data Management Technology

Research Finds Triple-Digit ROI in Market Data Management Technology TRG Screen launches ROI calculator to help firms model cost savings, efficiency gains and risk reduction GlobeNewswire February 24, 2026 New York, Feb. 24, 2026 (GLOBE NEWSWIRE) — New York, NY – February 24, 2026, TRG Screen, the leading provider of market data and subscription cost

Aebi Schmidt Group closes 2025 with exceptional order momentum, record Order Backlog, and significantly improved profitability; provides 2026 Financial Guidance and Board Update

Aebi Schmidt Group closes 2025 with exceptional order momentum, record Order Backlog, and significantly improved profitability; provides 2026 Financial Guidance and Board Update GlobeNewswire February 24, 2026 Exceptional order momentum with Order Intake in Q4 2025 increasing 46% vs Q4 2024, Order Backlog further grew to a multi-year record high of over $1.2b, providing a

Amber Therapeutics strengthens its Board and Leadership team, opens UK headquarters and expands EU feasibility study for mixed urinary incontinence, increasing momentum towards a pivotal trial in the US

Amber Therapeutics strengthens its Board and Leadership team, opens UK headquarters and expands EU feasibility study for mixed urinary incontinence, increasing momentum towards a pivotal trial in the US GlobeNewswire February 24, 2026 Oxford, UK – 24 February 2026 – Amber Therapeutics today announced a series of updates to its business highlighting the significant progress

Scroll to Top